School of Medicine, University of California, San Francisco, California; Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts.
J Am Acad Dermatol. 2013 Oct;69(4):550-6. doi: 10.1016/j.jaad.2013.05.029. Epub 2013 Jul 16.
European studies have shown that itch is a widespread symptom, yet little is known about its frequency in the United States.
We sought to describe ambulatory care visits to clinicians in the United States for which itch was coded as a patient symptom.
This study uses retrospective data from the National Ambulatory Medical Care Survey from 1999 through 2009.
Itch was coded as a symptom for an average of 7 million visits per year or approximately 1% of all outpatient visits, which was nearly 40% of the number of visits for the symptom of low back pain. Patients seen in visits for itch were more likely to be black or Asian than other patients (20% vs 14%). They were also more likely than other patients to receive a new medication (68% vs 36%) and were over twice as likely to receive 2 or more new medications (31% vs 14%).
Secondary data sets may not optimally capture patient reports and some of the procedures or medications may have been ordered for reasons other than itch.
Visits to clinicians for itch represent a sizeable proportion of ambulatory care visits in the United States, and research on the epidemiology, treatments, and causes of itch should be a priority.
欧洲的研究表明瘙痒是一种广泛存在的症状,但在美国,人们对其发病率知之甚少。
我们旨在描述美国门诊患者因瘙痒就诊的情况,即瘙痒被编码为患者症状。
本研究使用了 1999 年至 2009 年全国门诊医疗调查的回顾性数据。
瘙痒每年平均编码为 700 万次就诊症状,占所有门诊就诊的 1%左右,几乎是腰痛就诊症状的 40%。在瘙痒就诊中,患者更有可能是黑人或亚洲人,而不是其他种族(20%比 14%)。与其他患者相比,他们更有可能接受新的药物治疗(68%比 36%),接受 2 种或更多种新药物的可能性也高出一倍以上(31%比 14%)。
二次数据可能无法最佳地捕捉到患者的报告,并且一些程序或药物的使用可能并非出于瘙痒的原因。
看医生治疗瘙痒在美国的门诊就诊中占相当大的比例,因此应该优先研究瘙痒的流行病学、治疗方法和病因。